Pancreas transplantation in cross-match-positive recipients using cyclosporine- or tacrolimus-based immunosuppression

Transplant Proc. 2002 Aug;34(5):1901-2. doi: 10.1016/s0041-1345(02)03116-0.

Authors

K Khwaja¹, M Wijkstrom, A Gruessner, H Noreen, D E R Sutherland, R W Gruessner

Affiliation

¹ Department of Surgery, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN 55455, USA.

PMID: 12176621
DOI: 10.1016/s0041-1345(02)03116-0

No abstract available

MeSH terms

Cyclosporine / therapeutic use*
Histocompatibility Testing
Humans
Immunosuppressive Agents / therapeutic use*
Kidney Transplantation / immunology
Multivariate Analysis
Pancreas Transplantation / immunology*
Pancreas Transplantation / mortality
Postoperative Complications / classification
Postoperative Complications / epidemiology
Survival Rate
T-Lymphocytes / immunology*
Tacrolimus / therapeutic use*
Treatment Failure
Treatment Outcome

Substances

Immunosuppressive Agents
Cyclosporine
Tacrolimus